Werbung
Werbung

NUWE

NUWE logo

Nuwellis, Inc. Common Stock

2.00
USD
Gesponsert
+0.03
+1.78%
09. Jan., 15:55 UTC -5
Geschlossen
exchange

Nach-Markt

2.01

+0.01
+0.30%

NUWE Ergebnisberichte

Positives Überraschungsverhältnis

NUWE übertreffen die 16 der letzten 36Schätzungen.

44%

Nächster Bericht

Datum des nächsten Berichts
09. März 2026
Estimate for Q4 25 (Revenue/ EPS)
$2.36M
/
-$1.59
Implizierte Änderung von Q3 25 (Revenue/ EPS)
--
/
--
Implizierte Änderung von Q4 24 (Revenue/ EPS)
+1.47%
/
-94.59%

Nuwellis, Inc. Common Stock earnings per share and revenue

On 12. Nov. 2025, NUWE reported earnings of -- USD per share (EPS) for Q3 25, -- the estimate of -0.41 USD, resulting in a --% surprise. Revenue reached --, compared to an expected 2.55 million, with a --% difference. The market reacted with a -3.96% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 3 analysts forecast an EPS of -1.59 USD, with revenue projected to reach 2.36 million USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
AngioDynamics, Inc.
Report Date
06. Jan. 2026 For Q2 26
Estimate
-$0.10
Aktuell
$0.00
Überraschung
+100.00%
FAQ
For Q3 2025, Nuwellis, Inc. Common Stock reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
The stock price moved down -3.96%, changed from $2.78 before the earnings release to $2.67 the day after.
The next earning report is scheduled for 09. März 2026.
Based on 3 analysts, Nuwellis, Inc. Common Stock is expected to report EPS of -$1.59 and revenue of $2.36M for Q4 2025.
Scheck FXEmpire's Earnings Calendar for today's list of reporting companies.
Werbung